Mass spectrometric characterization of the hypoxia-inducible factor (HIF) stabilizer drug candidate BAY 85-3934 (molidustat) and its glucuronidated metabolite BAY-348, and their implementation into routine doping controls.
暂无分享,去创建一个
M. Thevis | W. Schänzer | C. Buisson | U. Thuss | J. Dib | C. Mongongu | A. Molina | Uwe Thuss